Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Rev Esp Enferm Dig ; 88(4): 253-7, 1996 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-9004795

RESUMO

The effects of indomethacin on pepsinogen secretion were studied in isolated human peptic cells prepared from endoscopically obtained biopsies after collagenase digestion, mechanical disruption and percoll gradient centrifugation. Low concentrations of indomethacin (10(-8)-10(-10) M) stimulated basal pepsinogen secretion. Higher doses of indomethacin (10(-5)-10(-6) M) potentiated histamine (10(-4) M) and db-cAMP (10(-4) M)-stimulated pepsinogen secretion without affecting acetylcholine (10(-6) M) and CCK-8-stimulated pepsinogen secretion or cell vitality. Increase of pepsinogen secretion was dependent on extracellular calcium because potentiation was abolished by calcium depletion of the medium. We conclude that indomethacin potentiates basal and secretagogue-stimulated pepsinogen secretion by dispersed human peptic cells and this might be an additional mechanism of NSAID-induced gastric injury. This potentiation effect is regulated by calcium and independent of endogenous prostaglandin inhibition.


Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Mucosa Gástrica/metabolismo , Indometacina/farmacologia , Pepsinogênios/metabolismo , Acetilcolina/farmacologia , Adulto , Idoso , Células Cultivadas , Colecistocinina/farmacologia , Meios de Cultura , AMP Cíclico/farmacologia , Sinergismo Farmacológico , Feminino , Mucosa Gástrica/citologia , Mucosa Gástrica/efeitos dos fármacos , Histamina/farmacologia , Humanos , Técnicas In Vitro , Indometacina/administração & dosagem , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...